Home › Companies › ANIKA THERAPEUTICS INC. › 2024-2025

ANIKA THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ANIKA THERAPEUTICS INC.’s Form 8-K, filed 2025-06-24 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 15Reported items
  • 188Asset managers
  • 2,004Fund votes
  • 2025-06-20Main meeting date

Proxy season: 2024-2025 2025-2026

Explore ANIKA THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ANIKA THERAPEUTICS INC.

These tallies are ANIKA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-24 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ANIKA THERAPEUTICS INC. — official shareholder meeting results, meeting held 2025-06-20
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Cheryl R. Blanchard, Ph.D. 8,754,7172,139,21551,074 --1,406,800 Majority: yes
Elect Director: Joseph H. Capper 10,521,730387,38535,891 --1,406,800 Majority: yes
Elect Director: Glenn R. Larsen, Ph.D. 8,712,9402,202,44129,625 --1,406,800 Majority: yes
PROPOSAL 4 Stockholders approved the Amendment with respect to the 2017 Plan. Stockholders voted as follows with respect to this proposal: 8,297,5632,608,92538,518 --1,406,800 Majority: yes

Source: ANIKA THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-24 — read the filing on EDGAR.

How asset managers voted at the ANIKA THERAPEUTICS INC. 2024-2025 meetings

Each item below shows how the 188 asset managers that disclosed a ANIKA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ANIKA THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2024-07-09; no official results are on file for this meeting.

Combines 4 wordings of this item as funds reported it.

99.7% fund support · no official result

FOR 99.7%

The 142 asset managers below cast 99.7% of the shares they voted on this item FOR (9,362,943 for, 22,557 against).

FOR: 9,362,943 (99.7%)AGAINST: 22,557 (0.2%)ABSTAIN: 1,448 (0.0%)
Largest asset managers voting on “ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Caligan Partners LP1,360,4500 00For
BlackRock1,332,4630 00For
Vanguard776,9820 00For
Dimensional719,8460 00For
BOOTHBAY FUND MANAGEMENT, LLC501,9500 00For
Renaissance474,4540 00For
Fidelity349,9720 00For
GEODE CAPITAL MANAGEMENT, LLC336,5440 00For
State Street308,8290 00For
Charles Schwab289,9690 00For
Nuveen176,9160 00For
TIAA164,8650 00For
DE Shaw154,9550 00For
SEI148,0790 00For
Meros Investment Management, LP143,2940 00For
Ensign Peak Advisors, Inc142,3810 00For
Northern Trust130,3750 00For
FRANKLIN MUTUAL ADVISERS LLC129,3150 00For
FRANKLIN VALUE INVESTORS TRUST129,3150 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP115,2970 00For
SEGALL BRYANT & HAMILL, LLC107,0050 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC104,3870 00For
GLOBEFLEX CAPITAL L P96,4350 00For
Two Sigma71,9770 00For
AQR71,5030 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

2. ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-20.

Combines 4 wordings of this item as funds reported it.

69% fund support · no official result

FOR 69%AGAINST 31%

The 140 asset managers below cast 69% of the shares they voted on this item FOR (4,830,749 for, 2,133,009 against).

FOR: 4,830,749 (69.4%)AGAINST: 2,133,009 (30.6%)NOT VOTED: 828 (0.0%)
Largest asset managers voting on “ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Caligan Partners LP01,434,130 00Against
BlackRock1,406,8750 00For
BOOTHBAY FUND MANAGEMENT, LLC0529,503 00Against
Renaissance362,1940 00For
GEODE CAPITAL MANAGEMENT, LLC331,5380 00For
Vanguard330,0630 00For
Fidelity318,2660 00For
Charles Schwab273,2340 00For
State Street198,2400 00For
DE Shaw148,6150 00For
Northern Trust111,5450 00For
Meros Investment Management, LP111,0560 00For
JACOBS LEVY EQUITY MANAGEMENT, INC94,7030 00For
GLOBEFLEX CAPITAL L P87,6000 00For
American Century077,298 00Against
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM68,0620 00For
Dimensional064,961 00Against
SEI59,3510 00For
ENVESTNET ASSET MANAGEMENT INC47,7531,563 00For
MELLON INVESTMENTS Corp48,7330 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/45,4490 00For
MFS45,4490 00For
Equitable43,5280 00For
Wellington41,4580 00For
Nuveen41,3150 00For

Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.

3. Election of three Class II Directors: Cheryl R. Blanchard, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-20.

Combines 3 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%AGAINST 20%
FOR: 8,754,717AGAINST: 2,139,215

ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Cheryl R. Blanchard, Ph.D.”): 8,754,717 for, 2,139,215 against, per its Form 8-K filed 2025-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,839,000 outstanding shares: 59% for, 14% against (73% of the company cast a for/against vote).

The 53 asset managers below cast 99.9% of the shares they voted on this item FOR (2,269,969 for, 1,202 against).

FOR 99.9%
FOR: 2,269,969 (99.9%)AGAINST: 1,202 (0.1%)NOT VOTED: 828 (0.0%)
Largest asset managers voting on “Election of three Class II Directors: Cheryl R. Blanchard, Ph.D.” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard765,1290 00For
BlackRock584,2290 00For
Fidelity311,9930 00For
Charles Schwab136,6170 00For
MFS45,4490 00For
Equitable43,5280 00For
TIAA40,9460 00For
American Century38,6490 00For
SEI29,3870 00For
Columbia Threadneedle24,9370 00For
QUANTITATIVE MASTER SERIES LLC22,6500 00For
Nationwide21,8020 00For
Goldman Sachs20,6640 00For
Bridge Builder Trust19,2710 00For
Thrivent15,8890 00For
FORUM FUNDS II14,9110 00For
Lincoln Financial12,3810 00For
State Street10,5080 00For
Northern Trust10,3370 00For
GuideStone9,9040 00For
MASTER INVESTMENT PORTFOLIO8,9590 00For
Global X7,8910 00For
WisdomTree7,6120 00For
John Hancock7,1930 00For
AIG/SunAmerica6,6220 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

4. Election of three Class II Directors: Glenn R. Larsen, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-20.

Combines 3 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%AGAINST 20%
FOR: 8,712,940AGAINST: 2,202,441

ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Glenn R. Larsen, Ph.D.”): 8,712,940 for, 2,202,441 against, per its Form 8-K filed 2025-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,839,000 outstanding shares: 59% for, 15% against (74% of the company cast a for/against vote).

The 53 asset managers below cast 99.0% of the shares they voted on this item FOR (2,249,803 for, 21,368 against).

FOR 99.0%
FOR: 2,249,803 (99.0%)AGAINST: 21,368 (0.9%)NOT VOTED: 828 (0.0%)
Largest asset managers voting on “Election of three Class II Directors: Glenn R. Larsen, Ph.D.” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard765,1290 00For
BlackRock584,2290 00For
Fidelity311,9930 00For
Charles Schwab136,6170 00For
MFS45,4490 00For
Equitable24,27819,250 00For
TIAA40,9460 00For
American Century38,6490 00For
SEI29,3870 00For
Columbia Threadneedle24,9370 00For
QUANTITATIVE MASTER SERIES LLC22,6500 00For
Nationwide21,8020 00For
Goldman Sachs20,6640 00For
Bridge Builder Trust19,2710 00For
Thrivent15,8890 00For
FORUM FUNDS II14,9110 00For
Lincoln Financial12,3810 00For
State Street10,5080 00For
Northern Trust10,3370 00For
GuideStone9,9040 00For
MASTER INVESTMENT PORTFOLIO8,9590 00For
Global X7,8910 00For
WisdomTree7,6120 00For
John Hancock7,1930 00For
AIG/SunAmerica6,6220 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

5. Election of three Class II Directors: Joseph H. Capper

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-20.

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 10,521,730AGAINST: 387,385

ANIKA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joseph H. Capper”): 10,521,730 for, 387,385 against, per its Form 8-K filed 2025-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,839,000 outstanding shares: 71% for, 3% against (74% of the company cast a for/against vote).

The 53 asset managers below cast 99.0% of the shares they voted on this item FOR (2,250,659 for, 20,512 against).

FOR 99.0%
FOR: 2,250,659 (99.1%)AGAINST: 20,512 (0.9%)NOT VOTED: 828 (0.0%)
Largest asset managers voting on “Election of three Class II Directors: Joseph H. Capper” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard765,1290 00For
BlackRock584,2290 00For
Fidelity311,9930 00For
Charles Schwab136,6170 00For
MFS45,4490 00For
Equitable24,27819,250 00For
TIAA40,9460 00For
American Century38,6490 00For
SEI29,3870 00For
Columbia Threadneedle24,9370 00For
QUANTITATIVE MASTER SERIES LLC22,6500 00For
Nationwide21,8020 00For
Goldman Sachs20,6640 00For
Bridge Builder Trust19,2710 00For
Thrivent15,8890 00For
FORUM FUNDS II14,9110 00For
Lincoln Financial12,3810 00For
State Street10,5080 00For
Northern Trust10,3370 00For
GuideStone9,9040 00For
MASTER INVESTMENT PORTFOLIO8,9590 00For
Global X7,8910 00For
WisdomTree7,6120 00For
John Hancock7,1930 00For
AIG/SunAmerica6,6220 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

6. APPROVAL OF THE AMENDMENT TO THE ANIKA THERAPEUTICS, INC. 2017 OMNIBUS INCENTIVE PLAN.

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-06-20.

76% Majority: yes · of votes cast

FOR 76%AGAINST 24%
FOR: 8,297,563AGAINST: 2,608,925

ANIKA THERAPEUTICS INC.’s own tally for this item (“PROPOSAL 4 Stockholders approved the Amendment with respect to the 2017 Plan. Stockholders voted as follows with respect to this proposal:”): 8,297,563 for, 2,608,925 against, per its Form 8-K filed 2025-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,839,000 outstanding shares: 56% for, 18% against (73% of the company cast a for/against vote).

The 52 asset managers below cast 92% of the shares they voted on this item FOR (2,062,782 for, 186,508 against).

FOR 92%8%
FOR: 2,062,782 (91.7%)AGAINST: 186,508 (8.3%)NOT VOTED: 828 (0.0%)
Largest asset managers voting on “APPROVAL OF THE AMENDMENT TO THE ANIKA THERAPEUTICS, INC. 2017 OMNIBUS INCENTIVE PLAN.” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard765,1290 00For
BlackRock584,2290 00For
Fidelity293,36118,632 00For
Charles Schwab136,6170 00For
MFS045,449 00Against
Equitable43,5280 00For
TIAA040,946 00Against
American Century038,649 00Against
SEI29,3870 00For
Columbia Threadneedle24,9370 00For
QUANTITATIVE MASTER SERIES LLC22,6500 00For
Nationwide21,8020 00For
Goldman Sachs20,6640 00For
Bridge Builder Trust5,67213,599 00Against
Thrivent15,8890 00For
Lincoln Financial2,9869,395 00Against
State Street7210,436 00Against
Northern Trust10,3370 00For
MASTER INVESTMENT PORTFOLIO8,9590 00For
Global X7,8910 00For
WisdomTree7,6120 00For
John Hancock7,1930 00For
AIG/SunAmerica6,6220 00For
Pacific Life5,9170 00For
Jackson National5,2440 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

7. Election of three Class I Directors: Stephen O. Richard

DIRECTOR ELECTIONS

Meeting held 2024-07-09; no official results are on file for this meeting.

Combines 4 wordings of this item as funds reported it.

88% fund support · no official result

FOR 88%12%

The 52 asset managers below cast 88% of the shares they voted on this item FOR (2,839,761 for, 379,792 against).

FOR: 2,839,761 (88.2%)AGAINST: 379,792 (11.8%)
Largest asset managers voting on “Election of three Class I Directors: Stephen O. Richard” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard763,9990 00For
Dimensional642,2010 00For
BlackRock548,7530 00For
Fidelity330,7780 00For
TIAA176,5470 00For
Charles Schwab0147,890 00Against
FRANKLIN VALUE INVESTORS TRUST0129,315 00Against
SEI074,943 00Against
MFS47,5510 00For
Virtus45,5790 00For
Equitable25,34318,800 00For
QUANTITATIVE MASTER SERIES LLC27,2840 00For
Thrivent26,2060 00For
American Century22,7300 00For
Lincoln Financial22,7210 00For
Bridge Builder Trust19,8160 00For
FORUM FUNDS II17,3140 00For
Goldman Sachs11,8770 00For
Northern Trust11,4060 00For
Voya9,3530 00For
State Street8,6341 00For
MASTER INVESTMENT PORTFOLIO7,5080 00For
AIG/SunAmerica7,4510 00For
AQR7,1580 00For
John Hancock6,9980 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

8. Election of three Class I Directors: William R. Jellison

DIRECTOR ELECTIONS

Meeting held 2024-07-09; no official results are on file for this meeting.

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (3,219,553 for, 0 against).

FOR: 3,219,553 (100.0%)
Largest asset managers voting on “Election of three Class I Directors: William R. Jellison” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard763,9990 00For
Dimensional642,2010 00For
BlackRock548,7530 00For
Fidelity330,7780 00For
TIAA176,5470 00For
Charles Schwab147,8900 00For
FRANKLIN VALUE INVESTORS TRUST129,3150 00For
SEI74,9430 00For
MFS47,5510 00For
Virtus45,5790 00For
Equitable44,1430 00For
QUANTITATIVE MASTER SERIES LLC27,2840 00For
Thrivent26,2060 00For
American Century22,7300 00For
Lincoln Financial22,7210 00For
Bridge Builder Trust19,8160 00For
FORUM FUNDS II17,3140 00For
Goldman Sachs11,8770 00For
Northern Trust11,4060 00For
Voya9,3530 00For
State Street8,6350 00For
MASTER INVESTMENT PORTFOLIO7,5080 00For
AIG/SunAmerica7,4510 00For
AQR7,1580 00For
John Hancock6,9980 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

9. RATIFICATION OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATED

Meeting held 2025-06-20.

99.9% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 99.9% of the shares they voted on this item FOR (2,246,295 for, 61 against).

FOR: 2,246,295 (100.0%)AGAINST: 61 (0.0%)NOT VOTED: 828 (0.0%)
Largest asset managers voting on “RATIFICATION OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED ACCOUNTING FIRM FOR THE FISCAL Y” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard765,1290 00For
BlackRock584,2290 00For
Fidelity311,9930 00For
Charles Schwab136,6170 00For
MFS45,4490 00For
Equitable43,5280 00For
TIAA40,9460 00For
American Century38,6490 00For
SEI29,3870 00For
Columbia Threadneedle24,9370 00For
QUANTITATIVE MASTER SERIES LLC22,6500 00For
Nationwide21,8020 00For
Goldman Sachs20,6640 00For
Bridge Builder Trust19,2710 00For
Thrivent15,8890 00For
Lincoln Financial12,3810 00For
State Street10,5071 00For
Northern Trust10,3370 00For
MASTER INVESTMENT PORTFOLIO8,9590 00For
Global X7,8910 00For
WisdomTree7,6120 00For
John Hancock7,1930 00For
AIG/SunAmerica6,6220 00For
Pacific Life5,9170 00For
Jackson National5,2440 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

10. Election of three Class I Directors: Sheryl L. Conley

DIRECTOR ELECTIONS

Meeting held 2024-07-09; no official results are on file for this meeting.

Combines 3 wordings of this item as funds reported it.

99.3% fund support · no official result

FOR 99.3%

The 51 asset managers below cast 99.3% of the shares they voted on this item FOR (3,182,236 for, 20,003 against).

FOR: 3,182,236 (99.4%)AGAINST: 20,003 (0.6%)
Largest asset managers voting on “Election of three Class I Directors: Sheryl L. Conley” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard763,9990 00For
Dimensional642,2010 00For
BlackRock548,7530 00For
Fidelity330,7780 00For
TIAA176,5470 00For
Charles Schwab147,8900 00For
FRANKLIN VALUE INVESTORS TRUST129,3150 00For
SEI74,9430 00For
MFS47,5510 00For
Virtus45,5790 00For
Equitable25,34318,800 00For
QUANTITATIVE MASTER SERIES LLC27,2840 00For
Thrivent26,2060 00For
American Century22,7300 00For
Lincoln Financial22,7210 00For
Bridge Builder Trust19,8160 00For
Goldman Sachs11,8770 00For
Northern Trust11,4060 00For
Voya9,3530 00For
State Street8,6341 00For
MASTER INVESTMENT PORTFOLIO7,5080 00For
AIG/SunAmerica7,4510 00For
AQR7,1580 00For
John Hancock6,9980 00For
Legg Mason6,6750 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

11. Ratification of appointment of Deloitte & Touche LLP as Anika's independent auditor for 2024; and

AUDIT-RELATED

Meeting held 2024-07-09; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 99.9% of the shares they voted on this item FOR (3,202,187 for, 52 against).

FOR: 3,202,187 (100.0%)AGAINST: 52 (0.0%)
Largest asset managers voting on “Ratification of appointment of Deloitte & Touche LLP as Anika's independent auditor for 2024; and” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard763,9990 00For
Dimensional642,2010 00For
BlackRock548,7530 00For
Fidelity330,7780 00For
TIAA176,5470 00For
Charles Schwab147,8900 00For
FRANKLIN VALUE INVESTORS TRUST129,3150 00For
SEI74,9430 00For
MFS47,5510 00For
Virtus45,5790 00For
Equitable44,1430 00For
QUANTITATIVE MASTER SERIES LLC27,2840 00For
Thrivent26,2060 00For
American Century22,7300 00For
Lincoln Financial22,7210 00For
Bridge Builder Trust19,8160 00For
Goldman Sachs11,8770 00For
Northern Trust11,4060 00For
Voya9,3530 00For
State Street8,6350 00For
MASTER INVESTMENT PORTFOLIO7,5080 00For
AIG/SunAmerica7,4510 00For
AQR7,1580 00For
John Hancock6,9980 00For
Legg Mason6,6750 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

12. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-20.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (35,222 for, 0 against).

FOR: 35,222 (100.0%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
FORUM FUNDS II14,9110 00For
JPMorgan10,4070 00For
GuideStone9,9040 00For

13. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2024-07-09; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (29,412 for, 0 against).

FOR: 29,412 (100.0%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
FORUM FUNDS II17,3140 00For
JPMorgan10,1280 00For
ALGERT GLOBAL LLC1,9700 00For

14. Amend Omnibus Stock Plan

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-06-20.

76% Majority: yes · of votes cast

FOR 76%AGAINST 24%
FOR: 8,297,563AGAINST: 2,608,925

ANIKA THERAPEUTICS INC.’s own tally for this item (“PROPOSAL 4 Stockholders approved the Amendment with respect to the 2017 Plan. Stockholders voted as follows with respect to this proposal:”): 8,297,563 for, 2,608,925 against, per its Form 8-K filed 2025-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,839,000 outstanding shares: 56% for, 18% against (73% of the company cast a for/against vote).

The 2 asset managers below cast 100% of the shares they voted on this item FOR (24,815 for, 0 against).

FOR 100%
FOR: 24,815 (100.0%)
Largest asset managers voting on “Amend Omnibus Stock Plan” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
FORUM FUNDS II14,9110 00For
GuideStone9,9040 00For

15. Ratify Deloitte & Touche LLP as Auditors

AUDIT-RELATED

Meeting held 2025-06-20.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (24,815 for, 0 against).

FOR: 24,815 (100.0%)
Largest asset managers voting on “Ratify Deloitte & Touche LLP as Auditors” at ANIKA THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
FORUM FUNDS II14,9110 00For
GuideStone9,9040 00For

Largest ANIKA THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked by the number of ANIKA THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 14,839,000 shares outstanding at the time of that meeting.

Top ANIKA THERAPEUTICS INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Caligan Partners LP 9.17%
2BlackRock 8.98%
3Vanguard 5.24%
4Dimensional 4.85%
5BOOTHBAY FUND MANAGEMENT, LLC 3.38%
6Renaissance 3.20%
7Fidelity 2.36%
8GEODE CAPITAL MANAGEMENT, LLC 2.27%
9State Street 2.08%
10Charles Schwab 1.95%

Reported ANIKA THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ANIKA THERAPEUTICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 10.24% 13F
Caligan Partners LP 9.67% 13D
BlackRock, Inc. 6.49% 13G
Vanguard Group 5.24% 13F
Dimensional Fund Advisors 4.14% 13F
Renaissance Technologies 3.56% 13F
State Street 2.20% 13F
Trigran Investments, Inc. 1.13% 13G
D.E. Shaw 1.13% 13F
Charles Schwab 1.01% 13F

Percentages above are of 14,839,000 shares outstanding, as reported by ANIKA THERAPEUTICS INC. on its Form 10-Q dated 2024-06-30 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ANIKA THERAPEUTICS INC.’s 10-Q dated 2024-06-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At ANIKA THERAPEUTICS INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held 2024-07-09 and 2025-06-20), 188 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,004 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. — the reporting funds cast 99.7% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

ANIKA THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.